Elsevier

Elsevier, a global leader in scientific information and analytics, offers a comprehensive suite of solutions tailored to support and enhance pharmacovigilance practices. Our life sciences portfolio combines cutting-edge technology with extensive scientific data to empower professionals in drug safety and risk management.

Key PV solutions we offer:

• PharmaPendium: A decision support solution providing access to FDA/EMA drug approval documents and comparative safety data.
• Embase: A biomedical literature database with advanced pharmacovigilance features for comprehensive adverse event monitoring.
• Reaxys: A chemistry database supporting drug-drug interaction analysis and impurity assessment.

These tools are designed to streamline regulatory compliance, improve signal detection, and facilitate evidence-based decision-making in pharmacovigilance.

Are you looking for a customized solution and advice? We offer custom data solutions (including FAIR) tailored to specific use cases, supported by domain expert teams.

We invite you to explore how Elsevier's solutions can enhance your organization's drug safety processes and contribute to better patient outcomes.

Please visit our website for more info: https://www.elsevier.com/industry/pharmaceuticals

Follow the latest Elsevier Life Sciences news on https://www.linkedin.com/showcase/elsevierforlifesciences/posts/?feedView=all

For questions, please contact Pierre van Doorn at p.doorn@elsevier.com